Evaluating vaccines for HIV prevention using nonhuman primates
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
['FUNDING_OTHER'] · UNIVERSITY OF LOUISIANA AT LAFAYETTE · NIH-10610273
This study is working on creating better HIV vaccines and prevention methods using monkeys to help find out how well these vaccines can protect against the virus, so we can eventually help people living with HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF LOUISIANA AT LAFAYETTE (nih funded) |
| Locations | 1 site (LAFAYETTE, UNITED STATES) |
| Trial ID | NIH-10610273 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines and prevention strategies through the use of nonhuman primates (NHPs). The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for preclinical studies, allowing researchers to assess the immune responses generated by candidate AIDS vaccines. By conducting thorough evaluations of vaccine efficacy and identifying correlates of reduced virus acquisition, this program aims to enhance the effectiveness of clinical vaccines. The SVEUs support all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to vaccination programs may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly improving public health outcomes.
How similar studies have performed: Previous research has shown success in using nonhuman primates for vaccine evaluation, indicating that this approach is both established and promising.
Where this research is happening
LAFAYETTE, UNITED STATES
- UNIVERSITY OF LOUISIANA AT LAFAYETTE — LAFAYETTE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VILLINGER, FRANCOIS — UNIVERSITY OF LOUISIANA AT LAFAYETTE
- Study coordinator: VILLINGER, FRANCOIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.